ASTHMA IN A PATIENT WITH COVID-19 : DOES IT PROTECT OR INCREASE THE RISKS?
OBJECTIVE: The aim: To investigate theimpact of asthma co-morbidity on the susceptibility and clinical course of COVID-19 in asthma patients.
PATIENTS AND METHODS: Materials and methods: Electronic databases of Pubmed and Google Scholar were searched using keyword searches.
CONCLUSION: Conclusions: Despite previous concerns about the increased risk of Covid-19 among asthmatics, most studies have not shown an increase in Covid-19 incidence among asthmatics compared to the general population. A large number of studies that have investigate the role of concomitant asthma in the susceptibility and severity of COVID-19, show conflicting results and indicate numerous factors that may affect these processes, so there is a need for large-scale studies to adjust the result to concomitant factors, which will assess the true impact of asthma on susceptibility and severity of COVID-19. Based on the recommendations of GINA 2020 regarding the management of asthma patients under Covid-19, potential protective effects of asthma therapy and the high risk of exacerbations when discontinuing basic therapy, we consider it appropriate to continue taking asthma patients therapy of asthma during a pandemic.
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:74 |
|---|---|
| Enthalten in: |
Wiadomosci lekarskie (Warsaw, Poland : 1960) - 74(2021), 5 vom: 01., Seite 1245-1249 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kochuieva, Maryna N [VerfasserIn] |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 08.06.2021 Date Revised 08.06.2021 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM32638538X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM32638538X | ||
| 003 | DE-627 | ||
| 005 | 20231225194459.0 | ||
| 007 | tu | ||
| 008 | 231225s2021 xx ||||| 00| ||eng c | ||
| 028 | 5 | 2 | |a pubmed24n1087.xml |
| 035 | |a (DE-627)NLM32638538X | ||
| 035 | |a (NLM)34090299 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kochuieva, Maryna N |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a ASTHMA IN A PATIENT WITH COVID-19 |b DOES IT PROTECT OR INCREASE THE RISKS? |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 08.06.2021 | ||
| 500 | |a Date Revised 08.06.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a OBJECTIVE: The aim: To investigate theimpact of asthma co-morbidity on the susceptibility and clinical course of COVID-19 in asthma patients | ||
| 520 | |a PATIENTS AND METHODS: Materials and methods: Electronic databases of Pubmed and Google Scholar were searched using keyword searches | ||
| 520 | |a CONCLUSION: Conclusions: Despite previous concerns about the increased risk of Covid-19 among asthmatics, most studies have not shown an increase in Covid-19 incidence among asthmatics compared to the general population. A large number of studies that have investigate the role of concomitant asthma in the susceptibility and severity of COVID-19, show conflicting results and indicate numerous factors that may affect these processes, so there is a need for large-scale studies to adjust the result to concomitant factors, which will assess the true impact of asthma on susceptibility and severity of COVID-19. Based on the recommendations of GINA 2020 regarding the management of asthma patients under Covid-19, potential protective effects of asthma therapy and the high risk of exacerbations when discontinuing basic therapy, we consider it appropriate to continue taking asthma patients therapy of asthma during a pandemic | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a asthma | |
| 650 | 4 | |a corticosteroid | |
| 700 | 1 | |a Psarova, Valentyna H |e verfasserin |4 aut | |
| 700 | 1 | |a Shklyar, Sergey P |e verfasserin |4 aut | |
| 700 | 1 | |a Oparin, Aleksey A |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Wiadomosci lekarskie (Warsaw, Poland : 1960) |d 1960 |g 74(2021), 5 vom: 01., Seite 1245-1249 |w (DE-627)NLM00001138X |x 0043-5147 |7 nnns |
| 773 | 1 | 8 | |g volume:74 |g year:2021 |g number:5 |g day:01 |g pages:1245-1249 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 74 |j 2021 |e 5 |b 01 |h 1245-1249 | ||